SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. (QUBT) is facing significant downward pressure and intense community debate as investors react to its recent financial performance, high short interest, and ongoing concerns about dilution. While proponents highlight the company's room-temperature photonics technology and potential for future contracts, skeptics are actively targeting the stock, citing poor revenue growth relative to spending and a broader slump across the quantum sector.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased attention as the community focuses on its post-quantum cryptography features and ongoing institutional developments. Investors are actively debating the project's long-term utility versus its recent market performance, with many currently split between accumulating at lower price levels and expressing frustration over the project's price action.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing increased investor activity and social media discussion as traders monitor speculative potential around potential pharmaceutical manufacturing contracts and broader industrial onshoring initiatives. While community sentiment remains split, bulls are closely tracking upcoming earnings and potential regulatory developments as key catalysts for a move back toward double-digit share prices.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is under heavy scrutiny following an 8-K filing regarding a $100 million loan agreement, where the company alleges that its collateral of Datavault AI shares was illegally sold without authorization, triggering a lawsuit against the lender and Bank of New York Mellon. While some community members view the legal action as a potential catalyst for recovering assets and exposing market manipulation, others remain deeply skeptical, citing the company's history of financial delays, dilution, and the CEO's controversial track record.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corporation is capturing significant market attention following the U.S. commercial launch of YARTEMLEA and a transformative licensing deal with Novo Nordisk that provides substantial upfront cash and long-term milestone potential. The community is actively debating the stock's future value based on the drug's first-mover status in the transplant-associated thrombotic microangiopathy (TA-TMA) space, while monitoring potential European expansion and the company's ability to maintain a strong cash position for ongoing pipeline development.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors closely monitor the upcoming earnings report and anticipate news regarding potential high-volume production orders from major hyperscale customers. The community is actively debating the company's ability to capitalize on AI infrastructure expansion, with many focused on whether recent technological validations will finally transition into sustained, scalable revenue growth.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading in a volatile range as investors closely monitor the upcoming FDA Type A meeting for its melanoma treatment, RP1. The community is actively debating the likelihood of a successful pathway to approval versus the potential for extended delays and long-term capital needs following the recent Complete Response Letter.

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Anika Therapeutics Inc.

Anika Therapeutics is under intense scrutiny as investors debate the impact of executive leadership changes and recent product updates on long-term growth. While some in the community see the recent stock buybacks and product pipeline as a potential catalyst for turnaround, others remain skeptical due to concerns over revenue execution and persistent profitability challenges.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

MATH is trending as the community debates potential for a breakout, with traders closely monitoring its low market cap, past volatility patterns, and speculative exchange listing rumors. Sentiment remains polarized between investors optimistic about a significant rally during altseason and those frustrated by consistent price stagnation and management concerns.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is rallying behind a significant $100M bank guarantee that effectively clears a major hurdle for its Phase 2 expansion, while an upgrade from Bank of America to a 'Buy' rating with a higher price target has further bolstered investor sentiment. The community is actively debating the stock's potential for a sustained breakout, with many bulls pointing to these operational milestones and increased institutional backing as signs that the company is successfully executing its growth strategy despite previous short-seller pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK) Sees Significant Growth in Short Interest

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) saw a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling 55,373...

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK) Raises Dividend to $0.21 Per Share

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK) announced a quarterly dividend on Thursday, February 19th. Shareholders of record on Wednesday, March 4th will be paid a dividend of 0.21 per...

James Abernethy Sells 523 Shares of Peoples Bancorp of North Carolina (NASDAQ:PEBK) Stock

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 523 shares of Peoples Bancorp of North Carolina stock in a transaction that occurred on Friday...

Peoples Bancorp of North Carolina (NASDAQ:PEBK) Director James Abernethy Sells 523 Shares

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 523 shares of the business's stock in a transaction on Friday, February 27th. The shares were...

Peoples Bancorp of North Carolina (NASDAQ:PEBK) Director Sells $22,896.00 in Stock

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 600 shares of the firm's stock in a transaction on Tuesday, February 24th. The stock was sold at...

Peoples Bancorp of North Carolina (NASDAQ:PEBK) Director James Abernethy Sells 600 Shares

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 600 shares of the business's stock in a transaction that occurred on Tuesday, February 24th. The...

Peoples Bancorp of North Carolina (NASDAQ:PEBK) Director Sells 1,000 Shares

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 1,000 shares of the business's stock in a transaction dated Monday, February 9th. The shares were...

James Abernethy Sells 1,000 Shares of Peoples Bancorp of North Carolina (NASDAQ:PEBK) Stock

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, February 9th. The...

Peoples Bancorp Stock Slips Post Q4 Earnings Despite Profit Growth

PEBK reports strong fourth-quarter 2025 profit growth, driven by higher NIM and a one-time property gain.

Peoples Bancorp Gains 25.6% in Six Months: How to Play the Stock?

PEBK posts steady earnings with loan growth, rising deposits and strong liquidity amid a tough rate environment.

Peoples Bancorp of North Carolina, Inc. is a holding company, which engages in the business of owning the Bank, Peoples Bank and PEBK Capital Trust II. It operates through the following segments: Banking Operations, Community Bank Real Estate Solutions, LLC (CBRES), and Other. The Banking Operations segment focuses on the consolidated bank. The CBRES segment provides appraisal management services to community banks. The company was founded in 1999 and is headquartered in Newton, NC.

Peoples Bancorp Of North Carolina Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$39.66
Prev Close	$39.51
Open	$39.09
Dividend Yield	2.21%
50-Day Moving Average	$38.01
Beta	0.75
Avg. Volume	25,211.42
PE Ratio	10.93

52-Week High	$40.74
52-Week Low	$23.63
Market Capitalization	$215.78M
EPS (Annual)	$3.62
Price to Book	1.38
Revenue Per Employee	$416,376.87

PEBK
Peoples Bancorp Of North Carolina Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PEBK News

PEBKPeoples Bancorp Of North Carolina Inc